Skip to main content

SAPIENS INTERNATIONAL CORP N V (SPNS) Stock Forecast 2025 - AI Price Prediction & Analysis


SAPIENS INTERNATIONAL CORP N V (SPNS) AI Stock Price Forecast & Investment Analysis

SAPIENS INTERNATIONAL CORP N V Stock Price Chart and Technical Analysis

Loading SAPIENS INTERNATIONAL CORP N V interactive price chart and technical analysis...

SAPIENS INTERNATIONAL CORP N V (SPNS) - Comprehensive Stock Analysis & Investment Research

Deep dive into SAPIENS INTERNATIONAL CORP N V's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about SAPIENS INTERNATIONAL CORP N V, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For SAPIENS INTERNATIONAL CORP N V: SAPIENS INTERNATIONAL CORP N V operates in the Technology sector, establishing it as a mid-cap growth opportunity.

SAPIENS INTERNATIONAL CORP N V (Stock Symbol: SPNS) is a leading company in the Technology sector , specifically operating within the Services-Prepackaged Software industry.

.

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing SAPIENS INTERNATIONAL CORP N V's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SAPIENS INTERNATIONAL CORP N V:

Market Capitalization: $2408 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for SAPIENS INTERNATIONAL CORP N V stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For SAPIENS INTERNATIONAL CORP N V: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for SAPIENS INTERNATIONAL CORP N V stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: SAPIENS INTERNATIONAL CORP N V's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For SAPIENS INTERNATIONAL CORP N V: Market positioning analysis based on available financial and operational metrics.

SAPIENS INTERNATIONAL CORP N V strategically competes in the highly dynamic Services-Prepackaged Software marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

SAPIENS INTERNATIONAL CORP N V (SPNS) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for SAPIENS INTERNATIONAL CORP N V stock analysis.

Loading SAPIENS INTERNATIONAL CORP N V comprehensive fundamental analysis and insider trading data...

Deep dive into SAPIENS INTERNATIONAL CORP N V's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if SAPIENS INTERNATIONAL CORP N V stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For SAPIENS INTERNATIONAL CORP N V:

P/B Ratio 5.02x
Market Cap $2408M
Book Value/Share $8.58
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently SAPIENS INTERNATIONAL CORP N V converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SAPIENS INTERNATIONAL CORP N V:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess SAPIENS INTERNATIONAL CORP N V's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For SAPIENS INTERNATIONAL CORP N V:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal SAPIENS INTERNATIONAL CORP N V's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For SAPIENS INTERNATIONAL CORP N V:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively SAPIENS INTERNATIONAL CORP N V uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For SAPIENS INTERNATIONAL CORP N V:

Understanding Financial Statement Data

What these metrics mean: Key figures from SAPIENS INTERNATIONAL CORP N V's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For SAPIENS INTERNATIONAL CORP N V:

Income Statement ($ Millions)
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 56M

Latest SAPIENS INTERNATIONAL CORP N V Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting SAPIENS INTERNATIONAL CORP N V (SPNS) stock price and investment outlook.

, source: MarketWatch

Sapiens International Corp. N.V. Annual cash flow by MarketWatch. View SPNS net cash flow, operating cash flow, operating expenses and cash dividends.

SAPIENS INTERNATIONAL CORP N V Competitors & Peer Analysis - Technology Sector

Comparative analysis of SAPIENS INTERNATIONAL CORP N V against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACIW Unlock Forecast - 30 Days FREE Trial $5324M 21.2x 3.8x
ADBE Unlock Forecast - 30 Days FREE Trial $141095M 20.3x 12.0x
AEYE Unlock Forecast - 30 Days FREE Trial $171M -61.5x 23.2x
AI Unlock Forecast - 30 Days FREE Trial $2571M -16.8x 3.2x
ALKT Unlock Forecast - 30 Days FREE Trial $2406M -75.9x 7.0x
ALRM Unlock Forecast - 30 Days FREE Trial $2522M 19.6x 3.2x
ALSAF Unlock Forecast - 30 Days FREE Trial $39M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
APCX Unlock Forecast - 30 Days FREE Trial $6M -0.8x 2.3x
API Unlock Forecast - 30 Days FREE Trial $1453M x 2.2x
APPN Unlock Forecast - 30 Days FREE Trial $2039M -27.3x -56.8x
ASAN Unlock Forecast - 30 Days FREE Trial $3325M -12.4x 14.8x
ATHR Unlock Forecast - 30 Days FREE Trial $70M x 11.8x
AVDX Unlock Forecast - 30 Days FREE Trial $2077M 1104.8x 3.0x
BAND Unlock Forecast - 30 Days FREE Trial $447M -30.3x 1.2x
BASE Unlock Forecast - 30 Days FREE Trial $1354M -10.2x 10.9x
BB Unlock Forecast - 30 Days FREE Trial $2678M -11.9x 3.7x
BBAI Unlock Forecast - 30 Days FREE Trial $3123M -3.9x 11.7x
BL Unlock Forecast - 30 Days FREE Trial $3075M 34.9x 7.4x
BLIN Unlock Forecast - 30 Days FREE Trial $15M -2.4x 1.5x
BLKB Unlock Forecast - 30 Days FREE Trial $3140M 88.2x 35.7x
BMR Unlock Forecast - 30 Days FREE Trial $43M x 2.4x
BNZI Unlock Forecast - 30 Days FREE Trial $8M x 2.6x
BRZE Unlock Forecast - 30 Days FREE Trial $2804M -36.2x 4.7x
BSQKZ Unlock Forecast - 30 Days FREE Trial $48641M 16.4x 2.2x
BSY Unlock Forecast - 30 Days FREE Trial $16767M 65.9x 14.4x
CANG Unlock Forecast - 30 Days FREE Trial $1004M x 0.3x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCLD Unlock Forecast - 30 Days FREE Trial $132M 11.7x 2.4x
CCLDO Unlock Forecast - 30 Days FREE Trial $906M 80.4x 16.2x
CCSI Unlock Forecast - 30 Days FREE Trial $510M 6.3x -8.3x
CDNS Unlock Forecast - 30 Days FREE Trial $89016M 88.0x 17.8x
CERT Unlock Forecast - 30 Days FREE Trial $1937M 242.7x 1.8x
CFLT Unlock Forecast - 30 Days FREE Trial $7714M -15.7x 7.3x
CGNT Unlock Forecast - 30 Days FREE Trial $639M x 3.2x
CHKP Unlock Forecast - 30 Days FREE Trial $21032M x 7.5x
CLBT Unlock Forecast - 30 Days FREE Trial $4755M x 11.6x
CLPS Unlock Forecast - 30 Days FREE Trial $13M x 0.8x
COUR Unlock Forecast - 30 Days FREE Trial $1685M -14.2x 2.7x
CRM Unlock Forecast - 30 Days FREE Trial $231618M 34.8x 3.8x
CRNC Unlock Forecast - 30 Days FREE Trial $458M -0.5x 2.9x
CRWD Unlock Forecast - 30 Days FREE Trial $121835M 4606.3x 32.4x
CRWV Unlock Forecast - 30 Days FREE Trial $49415M x 18.6x
CVLT Unlock Forecast - 30 Days FREE Trial $7758M 95.7x 21.3x
CWAN Unlock Forecast - 30 Days FREE Trial $4548M 11.2x 2.3x
CXM Unlock Forecast - 30 Days FREE Trial $1986M 16.5x 3.7x
CYBR Unlock Forecast - 30 Days FREE Trial $24283M x 10.3x
DAY Unlock Forecast - 30 Days FREE Trial $10898M 222.4x 4.0x
DDD Unlock Forecast - 30 Days FREE Trial $534M -3.9x 2.2x
DDOG Unlock Forecast - 30 Days FREE Trial $58124M 466.6x 18.2x
DH Unlock Forecast - 30 Days FREE Trial $427M -1.3x 1.4x
DOCU Unlock Forecast - 30 Days FREE Trial $13747M 48.9x 6.9x
DRTTF Unlock Forecast - 30 Days FREE Trial $119M 30.8x 3.5x
DSGX Unlock Forecast - 30 Days FREE Trial $8383M x 5.6x
DT Unlock Forecast - 30 Days FREE Trial $14537M 29.5x 5.4x
DTSS Unlock Forecast - 30 Days FREE Trial $15M -6.8x 5.3x
DUOL Unlock Forecast - 30 Days FREE Trial $16221M 138.4x 16.6x
EA Unlock Forecast - 30 Days FREE Trial $50250M 48.2x 8.3x
EGAN Unlock Forecast - 30 Days FREE Trial $366M 11.4x 4.5x
EVCM Unlock Forecast - 30 Days FREE Trial $2020M -59.0x 2.7x
EXFY Unlock Forecast - 30 Days FREE Trial $151M -12.3x 1.1x
FALC Unlock Forecast - 30 Days FREE Trial $1M x x
FATN Unlock Forecast - 30 Days FREE Trial $75M x 3.7x
FCUL Unlock Forecast - 30 Days FREE Trial $8M x 174.7x
FNGR Unlock Forecast - 30 Days FREE Trial $107M -16.8x 6.6x
FROG Unlock Forecast - 30 Days FREE Trial $5477M -60.2x 6.6x
FRSH Unlock Forecast - 30 Days FREE Trial $3309M -49.0x 3.4x
FRSX Unlock Forecast - 30 Days FREE Trial $1527M x 257.4x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1190M -8.6x 1.3x
GEG Unlock Forecast - 30 Days FREE Trial $108M 8.4x 1.5x
GEGGL Unlock Forecast - 30 Days FREE Trial $1087M 84.3x 15.5x
GHST Unlock Forecast - 30 Days FREE Trial $6M x x
GLBE Unlock Forecast - 30 Days FREE Trial $5776M x 6.5x
GMGI Unlock Forecast - 30 Days FREE Trial $138M -247.8x 1.1x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0.1x x
GTLB Unlock Forecast - 30 Days FREE Trial $7396M 654.1x 8.5x
GWRE Unlock Forecast - 30 Days FREE Trial $20303M 290.9x 13.9x
GXAI Unlock Forecast - 30 Days FREE Trial $13M -1.3x 0.9x
HPAI Unlock Forecast - 30 Days FREE Trial $130M x 8.0x
HUBS Unlock Forecast - 30 Days FREE Trial $24062M -5033.1x 11.7x
IDAI Unlock Forecast - 30 Days FREE Trial $9M -0.7x 3.9x
IFBD Unlock Forecast - 30 Days FREE Trial $9M x 0.1x
INFA Unlock Forecast - 30 Days FREE Trial $7537M 3931.5x 3.2x
INLX Unlock Forecast - 30 Days FREE Trial $53M 1318.3x 4.5x
INSE Unlock Forecast - 30 Days FREE Trial $240M 4.0x -116.0x
INTA Unlock Forecast - 30 Days FREE Trial $3085M -173.7x 5.9x
INTU Unlock Forecast - 30 Days FREE Trial $183432M 47.4x 9.3x
JAMF Unlock Forecast - 30 Days FREE Trial $1319M -22.8x 1.7x
KC Unlock Forecast - 30 Days FREE Trial $46548M x 4.9x
KLTR Unlock Forecast - 30 Days FREE Trial $229M 17.7x 13.5x
KVYO Unlock Forecast - 30 Days FREE Trial $6835M -19.1x 6.2x
LAW Unlock Forecast - 30 Days FREE Trial $375M -12.7x 2.7x
LFLY Unlock Forecast - 30 Days FREE Trial $112M -0.3x -4.0x
LPSN Unlock Forecast - 30 Days FREE Trial $590M -0.5x -1.2x
MANH Unlock Forecast - 30 Days FREE Trial $12126M 54.8x 43.5x
MBLY Unlock Forecast - 30 Days FREE Trial $12521M -9.4x 1.0x
MGIC Unlock Forecast - 30 Days FREE Trial $1042M x 5.0x
MLNK Unlock Forecast - 30 Days FREE Trial $1484M -46.1x 3.8x
MNDY Unlock Forecast - 30 Days FREE Trial $9674M x 8.1x
MQ Unlock Forecast - 30 Days FREE Trial $2312M 51.0x 2.7x
MSFT Unlock Forecast - 30 Days FREE Trial $3817879M 37.5x 11.1x
MTBLY Unlock Forecast - 30 Days FREE Trial $1608M x 33.3x
MTC Unlock Forecast - 30 Days FREE Trial $21M x x
MYPS Unlock Forecast - 30 Days FREE Trial $118M -24.1x 0.5x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0.4x 0.0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0.3x 0.5x
NABL Unlock Forecast - 30 Days FREE Trial $1441M 503.2x 1.8x
NCNO Unlock Forecast - 30 Days FREE Trial $2839M -119.0x 2.7x
NCSYF Unlock Forecast - 30 Days FREE Trial $8975M x 2.5x
NICE Unlock Forecast - 30 Days FREE Trial $8315M x 2.3x
NOW Unlock Forecast - 30 Days FREE Trial $189104M 113.9x 17.3x
ONTF Unlock Forecast - 30 Days FREE Trial $227M -6.7x 1.5x
OS Unlock Forecast - 30 Days FREE Trial $4078M x 10.6x
PATH Unlock Forecast - 30 Days FREE Trial $8936M 443.1x 5.4x
PAYC Unlock Forecast - 30 Days FREE Trial $11270M 27.1x 6.3x
PCOR Unlock Forecast - 30 Days FREE Trial $10854M -134.0x 8.9x
PCTY Unlock Forecast - 30 Days FREE Trial $8375M 36.9x 6.8x
PD Unlock Forecast - 30 Days FREE Trial $1484M -23.5x 8.2x
PLTR Unlock Forecast - 30 Days FREE Trial $426316M 558.5x 71.9x
PRCH Unlock Forecast - 30 Days FREE Trial $1791M 32.1x -22.8x
PRGS Unlock Forecast - 30 Days FREE Trial $1965M 40.5x 4.1x
PTC Unlock Forecast - 30 Days FREE Trial $24205M 47.2x 6.9x
QLYS Unlock Forecast - 30 Days FREE Trial $4612M 24.9x 9.1x
QTWO Unlock Forecast - 30 Days FREE Trial $3881M 794.6x 6.6x
RBLX Unlock Forecast - 30 Days FREE Trial $92385M -35.7x 261.6x
RBRK Unlock Forecast - 30 Days FREE Trial $15109M x 0.0x
RDVT Unlock Forecast - 30 Days FREE Trial $743M 85.4x 7.7x
RPD Unlock Forecast - 30 Days FREE Trial $1205M 47.2x 13.3x
RTCJF Unlock Forecast - 30 Days FREE Trial $40M x 1.5x
S Unlock Forecast - 30 Days FREE Trial $5611M -25.6x 3.7x
SAIL Unlock Forecast - 30 Days FREE Trial $12418M -73.2x 1.8x
SBET Unlock Forecast - 30 Days FREE Trial $1015M x 2.2x
SEMR Unlock Forecast - 30 Days FREE Trial $1080M 169.4x 3.9x
SHOP Unlock Forecast - 30 Days FREE Trial $200038M x 16.5x
SMSI Unlock Forecast - 30 Days FREE Trial $15M -0.2x 0.7x
SNAL Unlock Forecast - 30 Days FREE Trial $0M -7.0x 0.0x
SNPS Unlock Forecast - 30 Days FREE Trial $82300M 41.2x 3.0x
SPNS Unlock Forecast - 30 Days FREE Trial $2408M x 5.0x
SPSC Unlock Forecast - 30 Days FREE Trial $4144M 50.0x 4.4x
SSNC Unlock Forecast - 30 Days FREE Trial $20223M 25.1x 2.9x
SSTI Unlock Forecast - 30 Days FREE Trial $145M -38.0x 1.9x
SVCO Unlock Forecast - 30 Days FREE Trial $172M x 2.2x
TAOP Unlock Forecast - 30 Days FREE Trial $19M x 1.2x
TDC Unlock Forecast - 30 Days FREE Trial $2043M 18.6x 11.6x
TEAM Unlock Forecast - 30 Days FREE Trial $40936M -233.9x 30.4x
TENB Unlock Forecast - 30 Days FREE Trial $3522M -81.5x 10.0x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $8832M x 5.9x
TTWO Unlock Forecast - 30 Days FREE Trial $47524M -9.7x 13.7x
TWLO Unlock Forecast - 30 Days FREE Trial $17375M 858.3x 2.2x
TYL Unlock Forecast - 30 Days FREE Trial $24376M 79.5x 6.7x
U Unlock Forecast - 30 Days FREE Trial $15380M -13.5x 4.8x
VBIX Unlock Forecast - 30 Days FREE Trial $37M x 8.2x
VEEV Unlock Forecast - 30 Days FREE Trial $47139M 58.2x 7.1x
VPRB Unlock Forecast - 30 Days FREE Trial $M x x
VRNS Unlock Forecast - 30 Days FREE Trial $6852M -27.4x 20.1x
VWAV Unlock Forecast - 30 Days FREE Trial $23M x x
WBSR Unlock Forecast - 30 Days FREE Trial $M x x
WEAV Unlock Forecast - 30 Days FREE Trial $506M -36.7x 6.4x
WFCF Unlock Forecast - 30 Days FREE Trial $63M 30.7x 6.3x
WHEN Unlock Forecast - 30 Days FREE Trial $309M x 227.6x
WIMI Unlock Forecast - 30 Days FREE Trial $152M x 0.1x
XPER Unlock Forecast - 30 Days FREE Trial $350M -4.3x 0.8x
XYZ Unlock Forecast - 30 Days FREE Trial $47773M 16.2x 2.2x
ZDGE Unlock Forecast - 30 Days FREE Trial $43M -4.8x 1.5x
ZETA Unlock Forecast - 30 Days FREE Trial $4129M -26.5x 6.1x
ZSPC Unlock Forecast - 30 Days FREE Trial $29M x -3.2x

Frequently Asked Questions - SAPIENS INTERNATIONAL CORP N V Stock Forecast

How accurate are SAPIENS INTERNATIONAL CORP N V stock predictions?

Our AI model demonstrates 62% historical accuracy for SPNS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence SAPIENS INTERNATIONAL CORP N V stock price forecasts?

Our analysis considers SAPIENS INTERNATIONAL CORP N V's financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is SAPIENS INTERNATIONAL CORP N V a good investment in 2025?

Based on our AI analysis, SAPIENS INTERNATIONAL CORP N V shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are SAPIENS INTERNATIONAL CORP N V forecasts updated?

SAPIENS INTERNATIONAL CORP N V stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced SAPIENS INTERNATIONAL CORP N V Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for SAPIENS INTERNATIONAL CORP N V stock.

My Portfolio

Investment Dashboard

Loading your portfolio...